 | • レポートコード：MRC2Q12-02957 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ポマリドマイドAPIのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ポマリドマイドAPIのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ポマリドマイドAPIの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ポマリドマイドAPIのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのポマリドマイドAPIの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のポマリドマイドAPIの売上および2028年までの予測に焦点を当てています。 ポマリドマイドAPIのグローバル主要企業には、Mylan、Dr. Reddy's Laboratories、Hetero Drugs、Mac-Chem Products (India) Pvt.Ltd、Shilpa Medicare、Veranova、Natco Pharma Limited、Mehta API、Symed Labs Limited、Hangzhou Longshine Bio-Tech、Guangzhou Tosun Pharmaceutical、Sumar Biotech、Deva Holding ASなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ポマリドマイドAPI市場は、タイプとアプリケーションによって区分されます。世界のポマリドマイドAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 98%以上、99%以上 【アプリケーション別セグメント】 カプセル、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ポマリドマイドAPI製品概要 - タイプ別市場（98%以上、99%以上） - アプリケーション別市場（カプセル、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のポマリドマイドAPI販売量予測2017-2028 - 世界のポマリドマイドAPI売上予測2017-2028 - ポマリドマイドAPIの地域別販売量 - ポマリドマイドAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ポマリドマイドAPI販売量 - 主要メーカー別ポマリドマイドAPI売上 - 主要メーカー別ポマリドマイドAPI価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（98%以上、99%以上） - ポマリドマイドAPIのタイプ別販売量 - ポマリドマイドAPIのタイプ別売上 - ポマリドマイドAPIのタイプ別価格 ・アプリケーション別市場規模（カプセル、その他） - ポマリドマイドAPIのアプリケーション別販売量 - ポマリドマイドAPIのアプリケーション別売上 - ポマリドマイドAPIのアプリケーション別価格 ・北米市場 - 北米のポマリドマイドAPI市場規模（タイプ別、アプリケーション別） - 主要国別のポマリドマイドAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのポマリドマイドAPI市場規模（タイプ別、アプリケーション別） - 主要国別のポマリドマイドAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のポマリドマイドAPI市場規模（タイプ別、アプリケーション別） - 主要国別のポマリドマイドAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のポマリドマイドAPI市場規模（タイプ別、アプリケーション別） - 主要国別のポマリドマイドAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのポマリドマイドAPI市場規模（タイプ別、アプリケーション別） - 主要国別のポマリドマイドAPI市場規模（トルコ、サウジアラビア） ・企業情報 Mylan、Dr. Reddy's Laboratories、Hetero Drugs、Mac-Chem Products (India) Pvt.Ltd、Shilpa Medicare、Veranova、Natco Pharma Limited、Mehta API、Symed Labs Limited、Hangzhou Longshine Bio-Tech、Guangzhou Tosun Pharmaceutical、Sumar Biotech、Deva Holding AS ・産業チェーン及び販売チャネル分析 - ポマリドマイドAPIの産業チェーン分析 - ポマリドマイドAPIの原材料 - ポマリドマイドAPIの生産プロセス - ポマリドマイドAPIの販売及びマーケティング - ポマリドマイドAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ポマリドマイドAPIの産業動向 - ポマリドマイドAPIのマーケットドライバー - ポマリドマイドAPIの課題 - ポマリドマイドAPIの阻害要因 ・主な調査結果 |
Pomalidomide(CAS：19171-19-8) is a derivative of thalidomide marketed by Celgene.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Pomalidomide API estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Pomalidomide API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Pomalidomide API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Pomalidomide API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Pomalidomide API include Mylan, Dr. Reddy’s Laboratories, Hetero Drugs, Mac-Chem Products (India) Pvt.Ltd, Shilpa Medicare, Veranova, Natco Pharma Limited, Mehta API and Symed Labs Limited, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Pomalidomide API production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Pomalidomide API by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Pomalidomide API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Pomalidomide API market. Further, it explains the major drivers and regional dynamics of the global Pomalidomide API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Mylan
Dr. Reddy’s Laboratories
Hetero Drugs
Mac-Chem Products (India) Pvt.Ltd
Shilpa Medicare
Veranova
Natco Pharma Limited
Mehta API
Symed Labs Limited
Hangzhou Longshine Bio-Tech
Guangzhou Tosun Pharmaceutical
Sumar Biotech
Deva Holding AS
Market Segments
This report has explored the key segments: by Purity and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Pomalidomide API Segment by Purity
Above 98 %
Above 99 %
Pomalidomide API Segment by Application
Capsules
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Pomalidomide API production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Pomalidomide API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Pomalidomide API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Pomalidomide API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Pomalidomide API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pomalidomide API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Pomalidomide API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Pomalidomide API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Mylan, Dr. Reddy’s Laboratories, Hetero Drugs, Mac-Chem Products (India) Pvt.Ltd, Shilpa Medicare, Veranova, Natco Pharma Limited, Mehta API and Symed Labs Limited, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Pomalidomide API capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Pomalidomide API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pomalidomide API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by purity, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by purity, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by purity, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by purity, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by purity, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pomalidomide API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Pomalidomide API Product Introduction
1.2 Market by Purity
1.2.1 Global Pomalidomide API Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Market by Application
1.3.1 Global Pomalidomide API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Capsules
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Pomalidomide API Production
2.1 Global Pomalidomide API Production Capacity (2017-2028)
2.2 Global Pomalidomide API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Pomalidomide API Production by Region
2.3.1 Global Pomalidomide API Historic Production by Region (2017-2022)
2.3.2 Global Pomalidomide API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 China
2.6 India
2.7 Mid East & Africa
3 Global Pomalidomide API Sales in Volume & Value Estimates and Forecasts
3.1 Global Pomalidomide API Sales Estimates and Forecasts 2017-2028
3.2 Global Pomalidomide API Revenue Estimates and Forecasts 2017-2028
3.3 Global Pomalidomide API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Pomalidomide API Sales by Region
3.4.1 Global Pomalidomide API Sales by Region (2017-2022)
3.4.2 Global Sales Pomalidomide API by Region (2023-2028)
3.5 Global Pomalidomide API Revenue by Region
3.5.1 Global Pomalidomide API Revenue by Region (2017-2022)
3.5.2 Global Pomalidomide API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Pomalidomide API Production Capacity by Manufacturers
4.2 Global Pomalidomide API Sales by Manufacturers
4.2.1 Global Pomalidomide API Sales by Manufacturers (2017-2022)
4.2.2 Global Pomalidomide API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Pomalidomide API in 2021
4.3 Global Pomalidomide API Revenue by Manufacturers
4.3.1 Global Pomalidomide API Revenue by Manufacturers (2017-2022)
4.3.2 Global Pomalidomide API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Pomalidomide API Revenue in 2021
4.4 Global Pomalidomide API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Pomalidomide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Pomalidomide API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Pomalidomide API Sales by Purity
5.1.1 Global Pomalidomide API Historical Sales by Purity (2017-2022)
5.1.2 Global Pomalidomide API Forecasted Sales by Purity (2023-2028)
5.1.3 Global Pomalidomide API Sales Market Share by Purity (2017-2028)
5.2 Global Pomalidomide API Revenue by Purity
5.2.1 Global Pomalidomide API Historical Revenue by Purity (2017-2022)
5.2.2 Global Pomalidomide API Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Pomalidomide API Revenue Market Share by Purity (2017-2028)
5.3 Global Pomalidomide API Price by Purity
5.3.1 Global Pomalidomide API Price by Purity (2017-2022)
5.3.2 Global Pomalidomide API Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Pomalidomide API Sales by Application
6.1.1 Global Pomalidomide API Historical Sales by Application (2017-2022)
6.1.2 Global Pomalidomide API Forecasted Sales by Application (2023-2028)
6.1.3 Global Pomalidomide API Sales Market Share by Application (2017-2028)
6.2 Global Pomalidomide API Revenue by Application
6.2.1 Global Pomalidomide API Historical Revenue by Application (2017-2022)
6.2.2 Global Pomalidomide API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Pomalidomide API Revenue Market Share by Application (2017-2028)
6.3 Global Pomalidomide API Price by Application
6.3.1 Global Pomalidomide API Price by Application (2017-2022)
6.3.2 Global Pomalidomide API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Pomalidomide API Market Size by Purity
7.1.1 North America Pomalidomide API Sales by Purity (2017-2028)
7.1.2 North America Pomalidomide API Revenue by Purity (2017-2028)
7.2 North America Pomalidomide API Market Size by Application
7.2.1 North America Pomalidomide API Sales by Application (2017-2028)
7.2.2 North America Pomalidomide API Revenue by Application (2017-2028)
7.3 North America Pomalidomide API Sales by Country
7.3.1 North America Pomalidomide API Sales by Country (2017-2028)
7.3.2 North America Pomalidomide API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Pomalidomide API Market Size by Purity
8.1.1 Europe Pomalidomide API Sales by Purity (2017-2028)
8.1.2 Europe Pomalidomide API Revenue by Purity (2017-2028)
8.2 Europe Pomalidomide API Market Size by Application
8.2.1 Europe Pomalidomide API Sales by Application (2017-2028)
8.2.2 Europe Pomalidomide API Revenue by Application (2017-2028)
8.3 Europe Pomalidomide API Sales by Country
8.3.1 Europe Pomalidomide API Sales by Country (2017-2028)
8.3.2 Europe Pomalidomide API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Pomalidomide API Market Size by Purity
9.1.1 Asia Pacific Pomalidomide API Sales by Purity (2017-2028)
9.1.2 Asia Pacific Pomalidomide API Revenue by Purity (2017-2028)
9.2 Asia Pacific Pomalidomide API Market Size by Application
9.2.1 Asia Pacific Pomalidomide API Sales by Application (2017-2028)
9.2.2 Asia Pacific Pomalidomide API Revenue by Application (2017-2028)
9.3 Asia Pacific Pomalidomide API Sales by Region
9.3.1 Asia Pacific Pomalidomide API Sales by Region (2017-2028)
9.3.2 Asia Pacific Pomalidomide API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Pomalidomide API Market Size by Purity
10.1.1 Latin America Pomalidomide API Sales by Purity (2017-2028)
10.1.2 Latin America Pomalidomide API Revenue by Purity (2017-2028)
10.2 Latin America Pomalidomide API Market Size by Application
10.2.1 Latin America Pomalidomide API Sales by Application (2017-2028)
10.2.2 Latin America Pomalidomide API Revenue by Application (2017-2028)
10.3 Latin America Pomalidomide API Sales by Country
10.3.1 Latin America Pomalidomide API Sales by Country (2017-2028)
10.3.2 Latin America Pomalidomide API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pomalidomide API Market Size by Purity
11.1.1 Middle East and Africa Pomalidomide API Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Pomalidomide API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Pomalidomide API Market Size by Application
11.2.1 Middle East and Africa Pomalidomide API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Pomalidomide API Revenue by Application (2017-2028)
11.3 Middle East and Africa Pomalidomide API Sales by Country
11.3.1 Middle East and Africa Pomalidomide API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Pomalidomide API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Mylan
12.1.1 Mylan Corporation Information
12.1.2 Mylan Overview
12.1.3 Mylan Pomalidomide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Mylan Pomalidomide API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Mylan Recent Developments
12.2 Dr. Reddy’s Laboratories
12.2.1 Dr. Reddy’s Laboratories Corporation Information
12.2.2 Dr. Reddy’s Laboratories Overview
12.2.3 Dr. Reddy’s Laboratories Pomalidomide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Dr. Reddy’s Laboratories Pomalidomide API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Dr. Reddy’s Laboratories Recent Developments
12.3 Hetero Drugs
12.3.1 Hetero Drugs Corporation Information
12.3.2 Hetero Drugs Overview
12.3.3 Hetero Drugs Pomalidomide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Hetero Drugs Pomalidomide API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Hetero Drugs Recent Developments
12.4 Mac-Chem Products (India) Pvt.Ltd
12.4.1 Mac-Chem Products (India) Pvt.Ltd Corporation Information
12.4.2 Mac-Chem Products (India) Pvt.Ltd Overview
12.4.3 Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Mac-Chem Products (India) Pvt.Ltd Recent Developments
12.5 Shilpa Medicare
12.5.1 Shilpa Medicare Corporation Information
12.5.2 Shilpa Medicare Overview
12.5.3 Shilpa Medicare Pomalidomide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Shilpa Medicare Pomalidomide API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Shilpa Medicare Recent Developments
12.6 Veranova
12.6.1 Veranova Corporation Information
12.6.2 Veranova Overview
12.6.3 Veranova Pomalidomide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Veranova Pomalidomide API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Veranova Recent Developments
12.7 Natco Pharma Limited
12.7.1 Natco Pharma Limited Corporation Information
12.7.2 Natco Pharma Limited Overview
12.7.3 Natco Pharma Limited Pomalidomide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Natco Pharma Limited Pomalidomide API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Natco Pharma Limited Recent Developments
12.8 Mehta API
12.8.1 Mehta API Corporation Information
12.8.2 Mehta API Overview
12.8.3 Mehta API Pomalidomide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Mehta API Pomalidomide API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Mehta API Recent Developments
12.9 Symed Labs Limited
12.9.1 Symed Labs Limited Corporation Information
12.9.2 Symed Labs Limited Overview
12.9.3 Symed Labs Limited Pomalidomide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Symed Labs Limited Pomalidomide API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Symed Labs Limited Recent Developments
12.10 Hangzhou Longshine Bio-Tech
12.10.1 Hangzhou Longshine Bio-Tech Corporation Information
12.10.2 Hangzhou Longshine Bio-Tech Overview
12.10.3 Hangzhou Longshine Bio-Tech Pomalidomide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Hangzhou Longshine Bio-Tech Pomalidomide API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Hangzhou Longshine Bio-Tech Recent Developments
12.11 Guangzhou Tosun Pharmaceutical
12.11.1 Guangzhou Tosun Pharmaceutical Corporation Information
12.11.2 Guangzhou Tosun Pharmaceutical Overview
12.11.3 Guangzhou Tosun Pharmaceutical Pomalidomide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Guangzhou Tosun Pharmaceutical Pomalidomide API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Guangzhou Tosun Pharmaceutical Recent Developments
12.12 Sumar Biotech
12.12.1 Sumar Biotech Corporation Information
12.12.2 Sumar Biotech Overview
12.12.3 Sumar Biotech Pomalidomide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Sumar Biotech Pomalidomide API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Sumar Biotech Recent Developments
12.13 Deva Holding AS
12.13.1 Deva Holding AS Corporation Information
12.13.2 Deva Holding AS Overview
12.13.3 Deva Holding AS Pomalidomide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Deva Holding AS Pomalidomide API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Deva Holding AS Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Pomalidomide API Industry Chain Analysis
13.2 Pomalidomide API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Pomalidomide API Production Mode & Process
13.4 Pomalidomide API Sales and Marketing
13.4.1 Pomalidomide API Sales Channels
13.4.2 Pomalidomide API Distributors
13.5 Pomalidomide API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Pomalidomide API Industry Trends
14.2 Pomalidomide API Market Drivers
14.3 Pomalidomide API Market Challenges
14.4 Pomalidomide API Market Restraints
15 Key Finding in The Global Pomalidomide API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer